Supreme PLC (SUP)
London Exchange · UK · prices in GBX · close of 21 Oct 2026
Key indicators
| Last close | GBX 134.00 |
|---|---|
| 52-week range | 119.88 – 175.58 |
| Return, 1 month / 3 months | −2.9% / +4.9% |
| Return, 1 year / 3 years | −18.3% / +39.1% |
| Trend | Below its 200-day average |
| RSI (14) | 37 |
| Volatility (1 year) | 27.9% |
| Worst drawdown (1 year) | -30.4% |
| Average daily value traded | 17.37M GBX |
| Dividend yield | 0.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Supreme PLC is a British supplier of consumer products that it makes and distributes under its own brands and as own-label goods for retailers. Its range covers batteries, lighting, vaping devices and e-liquids, and sports nutrition supplements. Customers are mainly retailers such as supermarkets, discount stores and convenience chains, along with other outlets that stock everyday household and lifestyle products. The company is based in the United Kingdom and serves the domestic market while also supplying overseas customers.
The shares are listed on the London Exchange in UK under the code SUP, and the price on this page is in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Supreme PLC (SUP) trades on the London Exchange in UK. It last closed at GBX 134.00 on 21 October 2026.
Its price-based Market X-Ray is 51 out of 100 (a fair price profile), ranking 2,030 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 18.3% and over the last three months it rose 4.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 39 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -5.0% | ||
| From 52-week high | -22.8% | ||
| Momentum | 38 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 4.9% | ||
| 6-month return | -15.4% | ||
| 12-month return, skipping the last month | -15.9% | ||
| Stability (higher is calmer) | 57 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 27.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -30.4% | ||
| Liquidity | 78 · Strong | Trades actively. | |
| Average daily value traded | 17.37M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 52 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 0.0% | ||
| Years with dividends | 6 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −1.5% |
|---|---|
| 1 month | −2.9% |
| 3 months | +4.9% |
| 6 months | −15.4% |
| 1 year | −18.3% |
| 3 years | +39.1% |
| 5 years | −14.4% |
Signals
| 50-day / 200-day average | 140.72 / 141.04 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.94 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 20 Aug 2026 | GBP 0.0380 |
| 4 Dec 2025 | GBP 0.0160 |
| 21 Aug 2025 | GBP 0.0340 |
| 5 Dec 2024 | GBP 0.0180 |
| 22 Aug 2024 | GBP 0.0320 |
| 7 Dec 2023 | GBP 0.0150 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.